2011 EBM-hyperglycemia
|
|
- Alan Kennedy
- 8 years ago
- Views:
Transcription
1 嗎 2011 EBM-hyperglycemia 陳 莉 瑋 醫 師 一 定 要 打 打 bolus insulin? 用 FinePrint 列 印 - 可 在 訂 購
2 Question 1 Is bolus insulin necessary in DKA? P:DKA adult patient I:initial bolus insulin+insulin line C:insulin line O:reach the goal of glucose <250, ph>7.3, HCO3>15 Is a Priming Dose of Insulin Necessary in a Low-Dose Insulin Protocol for the Treatment of Diabetic Ketoacidosis? Abbas E Kitabchi, Mary Beth Murphy, Judy Spencer, Robert Matteri, Jim Karas. Diabetes Care. Alexandria:Nov Vol. 31, Iss. 11, p (5 pp.) The Evidence Pyramid Randomized Controlled Studies Cohort studies Case Control Studies Case series/ Reports Ideas, Editorials, Opinions Randomized Controlled Double Blind Studies Meta-analysis analysis Forest plot objective The purpose of this study was to assess the efficacy of an insulin priming dose with a continuous insulin infusion versus two continuous infusions without a priming dose. Animal research In vitro (test tube) research Hierarchy of evidence that arranges study designs by their susceptibility to bias.
3 人 人 人 This prospective randomized protocol used three insulin therapy methods: 1. load group (12 ):using a priming dose of 0.07 units of regular insulin per kg body weight followed by a dose of 0.07 unit /kg/ h i.v. 2. no load group(12 ) :using an infusion of regular insulin of 0.07 unit /kg/ h without a loading dose 3. twice no load group(13 ): using an infusion of regular insulin of 0.14 unit /kg/ h without a loading dose RESEARCH DESIGN AND METHODS Outcome based on the effects of insulin therapy on biochemical and hormonal changes during treatment and recovery of DKA. RESULTS The load group reached a peak in free insulin value (460 µu/ml) within 5 min and plateaued at 88 µu/ml in 60 min. The twice no load group reached a peak (200 µu/ml) at 45 min. The no load group reached a peak (60 µu/ml) in min. 5/12 in the no load group required supplemental insulin doses to decrease initial glucose levels by 10%; patients in the twice no load and load groups did not. Times to reach glucose 250 mg/dl, ph 7.3, and HCO- 15 meq/l did not differ significantly among the three groups.
4 CONCLUSIONS A priming dose in low-dose insulin therapy in patients with DKA is unnecessary if an adequate dose of regular insulin of 0.14 U/Kg/H is given. Q2:Any alternative to IV insulin in uncomplicate DKA? 多 所 以 花 很 有 多 其 錢 他 替 是 代 要 方 法 代 表 要 DKA and NKHS..? 用 FinePrint 列 印 - 可 在 訂 購 住 的 ICU P: uncomplicate DKA patient I:SC rapid-acting insulin analogs O:IV insulin infusion C: correction of DKA
5 The Evidence Pyramid Treatment of Diabetic Ketoacidosis With Subcutaneous Insulin Aspart Randomized Controlled Studies Cohort studies Randomized Controlled Double Blind Studies DIABETES CARE, VOLUME 27, NUMBER 8, AUGUST 2004 Case Control Studies Case series/ Reports Ideas, Editorials, Opinions Animal research In vitro (test tube) research Meta-analysis analysis Forest plot Hierarchy of evidence that arranges study designs by their susceptibility to bias. 排 除 challenge1000 OBJECTIVE In this prospective, randomized, open trial, we compared the efficacy and safety of aspart insulin given subcutaneously at different time intervals 仍 低 to 血 a standard low-dose intravenous (IV) infusion protocol of regular insulin in patients with uncomplicated diabetic ketoacidosis (DKA). Dementia,or pregnancy 壓,heart ischemia,esrd,liver failure,general edema 用 FinePrint 列 印 - 可 在 訂 購 RESEARCH DESIGN AND METHODS A total of 45 consecutive patients admitted with DKA were randomly assigned to receive subcutaneous (SC) aspart insulin every hour (SC-1h, n = 15) or every 2 h (SC-2h, n = 15) or to receive IV infusion of regular insulin (n = 15). Response to medical therapy was evaluated by assessing the duration of treatment until resolution of hyperglycemia and ketoacidosis. Additional end points included total length of hospitalization, amount of insulin administration until resolution of hyperglycemia and ketoacidosis, and number of hypoglycemic events.
6 RESULTS ± Admission biochemical parameters in patients treated with SC- 1h (glucose: 44 ±21 mmol/l [means ±SD], bicarbonate: 7.1 ±3 mmol/l, ph: 7.14 ±0.09) were similar to those treated with SC- 2h (glucose: 42 ±21 mmol/l, bicarbonate: 7.6 ±4 mmol/l, ph: 7.15 ±0.12) and IV regular insulin (glucose: 40 ±13 mmol/l, bicarbonate 7.1 ±4 mmol/l, ph: 7.11 ±0.17). There were no statistical differences in the mean duration of treatment until correction of hyperglycemia (6.9 ±4, 6.1 ±4, and 7.1 ±5 h) or until resolution of ketoacidosis (10 ±3, , and 11 ±3 h) among patients treated with SC-1h and SC-2h or with IV insulin, respectively (NS). There was no mortality and no differences in the length of hospital stay, total amount of insulin administration until resolution of hyperglycemia or ketoacidosis, or the number of hypoglycemic events among treatment groups. CONCLUSIONS Our results indicate that the use of subcutaneous insulin aspart every 1 or 2 h represents a safe and effective alternative to the use of intravenous regular insulin in the management of patients with uncomplicated DKA.
7 綜 合 Q1 和 Q2 的 結 論 Insulin control 0.14U/KG/hr IV continuous Insulin infusion Back to our protocol
8 cardiorespiratory stable Determine hydration status Fluid supplement first hyperg-2 1.ABC 2.CBC/DC,CRP 3.Blood osmo,sugar,bun,cr,na,k,cl,urine and blood ketone,alt,ckmb,trop-i 4.Vein gas 5.EKG 6.CXR,urine routine..ect fever survey and culture 7. NS 1L/Hr RI 0.1U/Kg bolus IV stat Urine routine and ketone Infection control B/C,U/C,Sp/C if need Hyper A1 Diagnosis:HHNK 1.On ciritical 2.Vital sign Q4H 如 果 可 以 3.If k<3.3,give K first and hold RI line 4.Fluid and RI line a)ri line:ri50u+n/s 500 ml run 1ml/kg/hr b) Half saline 250ml/hr Or NS 250 ml/hr if low Na 5.F/S Q1H 6.Na,K,vein gas Q2H 7.Record I/O 8.K supply in fluid if K<5.3 to keep k level(4-5) 9.Admission to meta Hyper A2 Diagnosis:DKA 1.On ciritical 如 果 可 以 2.Vital sign Q4H 3.If k<3.3,give K first and hold RI line 4.Fluid and RI line a)ri line:ri50u+n/s 500 ml run 1ml/kg/hr b) Half saline 250ml/hr Or NS 250 ml/hr if low Na 5.F/S Q1H 6.Na,K,vein gas Q2H 7.Record I/O 8.K supply in fluid if K<5.3 to keep k level(4-5) 9.Give NaHCO3 only if ph< Admission to meta 觀 察 室 時 DKA:200 HHNK:300 Thank you for your attention!
Mind the Gap: Navigating the Underground World of DKA. Objectives. Back That Train Up! 9/26/2014
Mind the Gap: Navigating the Underground World of DKA Christina Canfield, MSN, RN, ACNS-BC, CCRN Clinical Nurse Specialist Cleveland Clinic Respiratory Institute Objectives Upon completion of this activity
More informationElectronic copy to all appropriate staff Intranet Notification in Staff Focus Related Trust Policies (to be read in conjunction with)
Diabetes Management for Children and Young People undergoing Surgery (0-16 yrs) Clinical Guideline Register No: 10096 Status: Public Developed in response to: Updated national guidelines Contributes to
More informationDAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES
One Children s Plaza Dayton, OH 45404-1815 www.childrensdayton.org DAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES DISCLAIMER: This Clinical Practice Guideline (CPG) generally describes a recommended
More informationtips Insulin Pump Users 1 Early detection of insulin deprivation in continuous subcutaneous 2 Population Study of Pediatric Ketoacidosis in Sweden:
tips Top International Publications Selection Insulin Pump Users Early detection of insulin deprivation in continuous subcutaneous insulin infusion-treated Patients with TD Population Study of Pediatric
More information[ ] POCT glucose Routine, As needed, If long acting insulin is given and patient NPO, do POCT glucose every 2 hours until patient eats.
Glycemic Control - Insulin Infusion NOTE: For treatment of Diabetic Ketoacidosis or Hyperglycemic Hyperosmolar Syndrome please go to order set named Diabetic Ketoacidosis (DKA) and Hyperglycemic Hyperosmolar
More informationIn-hospital management of diabetes
Dr. Tom Elliott MBBS, FRCPC Medical Direct 4102 2775 Laurel St. phone: 604.675.2491 Vancouver, BC fax: 604.875.5931 V5Z 1M9 Canada email: info@bcdiabetes.ca In-hospital management of diabetes General Management
More informationINPATIENT DIABETES MANAGEMENT Robert J. Rushakoff, MD Professor of Medicine Director, Inpatient Diabetes University of California, San Francisco
INPATIENT DIABETES MANAGEMENT Robert J. Rushakoff, MD Professor of Medicine Director, Inpatient Diabetes University of California, San Francisco CLINICAL RECOGNITION Background: Appropriate inpatient glycemic
More informationDiabetic Ketoacidosis
Princess Margaret Hospital for Children PAEDIATRIC ACUTE CARE GUIDELINE Diabetic Ketoacidosis Scope (Staff): Scope (Area): All Emergency Department Clinicians Emergency Department This document should
More informationROYAL HOSPITAL FOR WOMEN
ROYAL HOSPITAL FOR WOMEN LOCAL OPERATING PROCEDURE CLINICAL POLICIES, PROCEDURES & GUIDELINES Approved by Quality & Patient Safety Committee 17 April 2014 INSULIN INFUSION PROTOCOL INSULIN DEXTROSE INFUSION
More informationTreatment of Diabetic Ketoacidosis With Subcutaneous Insulin Aspart
Clinical Care/Education/Nutrition O R I G I N A L A R T I C L E Treatment of Diabetic Ketoacidosis With Subcutaneous Insulin Aspart GUILLERMO E. UMPIERREZ, MD, FACP, FACE 1 RUBEN CUERVO, MD 2 ANA KARABELL,
More informationHyperosmolar Non-Ketotic Diabetic State (HONK)
Hyperosmolar Non-Ketotic Diabetic State (HONK) University Hospitals of Leicester NHS Trust Guidelines for Management of Acute Medical Emergencies Management is largely the same as for diabetic ketoacidosis
More informationUniversity of Gezira. Faculty of Medicine. Department of Paediatrics and Child Health. Integrated Management of Diabetes in Children (IMDC) Project
University of Gezira Faculty of Medicine Department of Paediatrics and Child Health Integrated Management of Diabetes in Children (IMDC) Project Guidelines for Diabetes Management in Children 2007 1 These
More informationDiabetic Ketoacidosis: When Sugar Isn t Sweet!!!
Diabetic Ketoacidosis: When Sugar Isn t Sweet!!! W Ricks Hanna Jr MD Assistant Professor of Pediatrics University of Tennessee Health Science Center LeBonheur Children s Hospital Introduction Diabetes
More informationCARDIAC SURGERY INTRAVENOUS INSULIN PROTOCOL PHYSICIAN ORDERS INDICATIONS EXCLUSIONS. Insulin allergy
Page 1 of 5 INDICATIONS EXCLUSIONS 2 consecutive blood glucose measurements greater than 110 mg per dl AND NPO with a continuous caloric source AND Diagnosis of : Cardio-thoracic Surgery NOTE: This protocol
More informationUniversity College Hospital. Sick day rules insulin pump therapy
University College Hospital Sick day rules insulin pump therapy Children and Young People s Diabetes Service Children whose diabetes is well controlled should not experience more illness or infections
More informationDIABETIC COMPLICATIONS
Diabetic Complications Ladan Mohammad-Zadeh, DVM, DACVECC Diabetes mellitus is a disease of glucose dysregulation secondary to relative insulin resistance (non-insulin dependent diabetes mellitus) or an
More informationUser guide Basal-bolus Insulin Dosing Chart: Adult
Contacts and further information Local contact Clinical pharmacy or visiting pharmacy Diabetes education service Director of Medical Services Visiting or local endocrinologist or diabetes physician For
More informationA new insulin order form should be completed for subsequent changes to type of insulin and/or frequency of administration
of nurse A new insulin order form should be completed for subsequent changes to type of insulin and/or frequency of administration 1. Check times for point of care meter blood glucose testing. Pre-Breakfast
More information4/15/2013. Maribeth Inturrisi RN MS CNS CDE Perinatal Diabetes Educator mbturris@comcast.net
Maribeth Inturrisi RN MS CNS CDE Perinatal Diabetes Educator mbturris@comcast.net List the potential complications associated with diabetes during labor. Identify the 2 most important interventions essential
More informationDiabetes Prevention Trial - Type 1. INSULIN INFUSION FLOW-SHEET Page 1 of 6
Diabetes Prevention Trial - Type 1 Form IF INSULIN INFUSION FLOW-SHEET Page 1 of 6 Subject ID #: Subject Initials: Testing Location Code: F M L (use codes provided by DMU) Physician s signature: Name of
More informationContinuous Subcutaneous Insulin Infusion (CSII)
IMPORTANCE OF FOCUS CSII (Insulin pumps) have been used for more than 35 years. In the U.S. in 2005, the level of insulin pump penetration was estimated at 20 to 30% in patients with type 1 diabetes mellitus
More informationObjectives PERINATAL INSULIN PUMPS: BASICS FOR NURSES. Historical Perspective. Insulin Pumps in Pregnancy. Insulin Pumps in the US
Objectives PERINATAL INSULIN PUMPS: BASICS FOR NURSES Jo M. Kendrick, APN BC, CDE jkendric@utmck.edu Describe indications and contraindications for insulin pump use in hospitalized patients Differentiate
More informationLothian Diabetes Handbook MANAGEMENT OF DIABETIC KETOACIDOSIS
MANAGEMENT OF DIABETIC KETOACIDOSIS 90 MANAGEMENT OF DIABETIC KETOACIDOSIS Diagnosis elevated plasma and/or urinary ketones metabolic acidosis (raised H + /low serum bicarbonate) Remember that hyperglycaemia,
More informationAdult CCRN/CCRN E/CCRN K Certification Review Course: Endocrine 12/2015. Endocrine 1. Disclosures. Nothing to disclose
Adult CCRN/CCRN E/CCRN K Certification Review Course: Carol Rauen RN BC, MS, PCCN, CCRN, CEN Disclosures Nothing to disclose 1 Body Harmony disorders and emergencies Body Harmony (cont) Introduction Disorders
More informationDKA & HYPERGLYCEMIC HYPEROSMOLAR STATE (HHS) D. Franzon, MD
DKA & HYPERGLYCEMIC HYPEROSMOLAR STATE (HHS) D. Franzon, MD Pathogenesis: Physiology Diabetic ketoacidosis (DKA) is probably the most commonly encountered metabolic disorder in the PICU. The incidence
More informationCLASS OBJECTIVES. Describe the history of insulin discovery List types of insulin Define indications and dosages Review case studies
Insulins CLASS OBJECTIVES Describe the history of insulin discovery List types of insulin Define indications and dosages Review case studies INVENTION OF INSULIN 1921 The first stills used to make insulin
More informationCSII (CONTINUOUS SUBCUTANEOUS INSULIN INFUSION) AND INPATIENT ADMISSION
CSII (CONTINUOUS SUBCUTANEOUS INSULIN INFUSION) AND INPATIENT ADMISSION Goals of Inpatient Glucose Management Avoid Hypoglycemia (Serum glucose
More informationSECTION: NM NUMBER: 20. HENRY FORD HOSPITAL DETROIT, MICHIGAN TITLE: GLYCEMIC CONTROL INTENSIVE CARE PROTOCOL UNIT: All ICUs
CLINICALPROTOCOL MULTIDISCIPLINARY SECTION: NM NUMBER: 2 HENRY FORD HOSPITAL DETROIT, MICHIGAN TITLE: GLYCEMIC CONTROL INTENSIVE CARE PROTOCOL UNIT: All ICUs APPROVED: 3/3 REVIEWED: REVISED: 12/3, 5/,
More informationINTERNAL MEDICINE RESIDENTS NOON CONFERENCE: INPATIENT GLYCEMIC CONTROL
INTERNAL MEDICINE RESIDENTS NOON CONFERENCE: INPATIENT GLYCEMIC CONTROL Presented by: Leyda Callejas PGY5 Endocrinology, Diabetes and Metabolism Acknowledgements: Dr. P Orlander Dr. V Lavis Dr. N Shah
More informationDIABETIC KETOACIDOSIS PATHWAY EMERGENCY DEPARTMENT MANAGEMENT GUIDELINES (This is NOT an order) 3/2012
DIABETIC KETOACIDOSIS PATHWAY EMERGENCY DEPARTMENT MANAGEMENT GUIDELINES (This is NOT an order) 3/2012 Note: this is only an outline. Please refer to "Guidelines for Management of Diabetic Ketoacidosis"
More informationSponsor. Novartis Generic Drug Name. Vildagliptin. Therapeutic Area of Trial. Type 2 diabetes. Approved Indication. Investigational.
Clinical Trial Results Database Page 1 Sponsor Novartis Generic Drug Name Vildagliptin Therapeutic Area of Trial Type 2 diabetes Approved Indication Investigational Study Number CLAF237A2386 Title A single-center,
More informationInsulin Treatment. J A O Hare. www.3bv.org. Bones, Brains & Blood Vessels
Insulin Treatment J A O Hare www.3bv.org Bones, Brains & Blood Vessels Indications for Insulin Treatment Diabetic Ketoacidosis Diabetics with unstable acute illness ICU Gestational Diabetes: diet failure
More informationImplementing The Portland Protocol - Continuous Intravenous Insulin Infusion in your institution
Implementing The Portland Protocol - Continuous Intravenous Insulin Infusion in your institution Anthony P. Furnary, MD St Vincent Medical Center Providence Health Systems Portland, OR Phased Implementation
More informationInsulin Pump Therapy during Pregnancy and Birth
Approvals: Specialist Group: Miss F Ashworth, Dr I Gallen, Dr J Ahmed Maternity Guidelines Group: V1 Dec 2012 Directorate Board: V1 Jan 2013 Clinical Guidelines Subgroup: July 2011 MSLC: V1 Nov 2012 Equality
More informationDiabetes in Pregnancy: Management in Labour
1. Purpose The standard management of labour applies to women with diabetes, and includes the following special considerations: Timing of birth. Refer to guideline: Diabetes Mellitus - Management of Pre-existing
More informationSHINE Study Ordering Instructions for Investigators SUNY Downstate
General Directions SHINE Study Ordering Instructions for Investigators SUNY Downstate 1) Call Spiro Demetis to get patient admitted to ICU ASAP. Cell: 646-261-5730; Pager: 917-760-1653. Let him know that
More informationGlucose Management University of Colorado Hospital
Glucose Management University of Colorado Hospital Bridget Everhart, MSN, NP, CDE Inpatient Diabetes Educator Bridget.Everhart@uch.edu M F Pager 303 266-7898 UCH Diabetes Program Michael McDermott MD Diabetes
More informationInsulin Pump Therapy and Continuous Glucose Sensor Use in the Management of Diabetes Mellitus
Insulin Pump Therapy and Continuous Glucose Sensor Use in the Management of Diabetes Mellitus Louis Haenel, IV, DO, FACOI, FACE Endocrinology Roper Hospital Charleston, SC Dr. Louis Haenel IV has disclosed
More informationSupplementary appendix
Supplementary appendix This appendix formed part of the original submission and has been peer reviewed. We post it as supplied by the authors. Supplement to: Haidar A, Legault L, Matteau-Pelletier L, et
More informationReplacement post-filter (ml/hr) Blood flow (ml/min) Dialysate (ml/hr) Weight (kg)
404FM.1 CONTINUOUS RENAL REPLACEMENT THERAPY (CRRT) USING CITRATE Target Audience: Hospital only ICU (Based on Gambro and Kalmar Hospital protocols) CRRT using regional citrate anticoagulation This is
More informationPrior Authorization Guideline
Prior Authorization Guideline Guideline: PC - Apidra, Levemir Therapeutic Class: Hormones and Synthetic Substitutes Therapeutic Sub-Class: Antidiabetic Agents Client: CA, CO, NV, OK, OR, WA and AZ Approval
More informationWho is suitable for CSII, Why and How to Access Pump Therapy Mary Bilous and Sue Winship Diabetes Specialist Nurses James Cook University Hospital
Who is suitable for CSII, Why and How to Access Pump Therapy Mary Bilous and Sue Winship Diabetes Specialist Nurses James Cook University Hospital What is CSII? Insulin pump therapy or Continuous Subcutaneous
More informationIntensive Insulin Therapy in Diabetes Management
Intensive Insulin Therapy in Diabetes Management Lillian F. Lien, MD Medical Director, Duke Inpatient Diabetes Management Assistant Professor of Medicine Division of Endocrinology, Metabolism, & Nutrition
More informationGESTATIONAL DIABETES (DIET/INSULIN/METFORMIN) CARE OF WOMEN IN BIRTHING SUITE
GESTATIONAL DIABETES (DIET/INSULIN/METFORMIN) CARE OF WOMEN IN BIRTHING SUITE DEFINITION A disorder characterised by hyperglycaemia first recognised during pregnancy due to increased insulin resistance
More informationSuffolk County Community College School of Nursing NUR 133 ADULT NURSING I
Suffolk County Community College School of Nursing NUR 133 ADULT NURSING I Page # 1 Instructions for students: Case study # 1 For this lab, you are planning to provide care to the following client: CB
More informationDiabetes: When To Treat With Insulin and Treatment Goals
Diabetes: When To Treat With Insulin and Treatment Goals Lanita. S. White, Pharm.D. Director, UAMS 12 th Street Health and Wellness Center Assistant Professor of Pharmacy Practice, UAMS College of Pharmacy
More informationDiabetic Emergencies. David Hill, D.O.
Diabetic Emergencies David Hill, D.O. Class Outline Diabetic emergency/glucometer training Identify the different signs of insulin shock Diabetic coma, and HHNK Participants will understand the treatment
More informationAdvanced Practice Provider Academy
(+)Corey M. Slovis, MD, FACEP Professor, Emergency Medicine and Medicine; Chairman, Department of Emergency Medicine, Vanderbilt University Medical Center, Nashville, Tennessee; Medical Director, Metro
More informationMy Sick Day Plan for Type 1 Diabetes on an Insulin Pump
My Sick Day Plan for Type 1 Diabetes on an Insulin Pump When you are sick, your blood sugar levels may be harder to keep under control. Your blood sugar may go too high or too low. Use this guide to help
More informationDehydration and Fluid Therapy Guide
Dehydration and Fluid Therapy Guide Background: Dehydration occurs when the loss of body fluids (mainly water) exceeds the amount taken in. Fluid loss can be caused by numerous factors such as: fever,
More informationUse of Continuous Subcutaneous Insulin Infusion (CSII) Pumps in Hospitalized Patients Policy and Procedure
Purpose: To ensure safe and accurate administration of insulin for patients using their own external continuous subcutaneous insulin infusion pump during hospitalization. Definitions: Insulin pump: An
More informationGlycemic Control Initiative: Insulin Order Set Changes Hypoglycemia Nursing Protocol
Glycemic Control Initiative: Insulin Order Set Changes Hypoglycemia Nursing Protocol Ruth LaCasse Kalish, RPh Department of Pharmacy Objectives Review the current practice at UConn Health with sliding
More informationThe mainstay in the treatment of patients with diabetic
CLINICAL STUDIES Efficacy of Subcutaneous Insulin Lispro versus Continuous Intravenous Regular Insulin for the Treatment of Patients with Diabetic Ketoacidosis Guillermo E. Umpierrez, MD, Kashif Latif,
More informationTaking Insulin Pumps to School. Rachel Calendo, MS, RN, CPNP, CDE, Martha Cuevas, RN, BSN, CPT
Taking Insulin Pumps to School Rachel Calendo, MS, RN, CPNP, CDE, Martha Cuevas, RN, BSN, CPT Insulin Pumps Today A micro-computer, about the size of a pager Programmed to deliver both a preset amount
More informationDiabetes Management Tube Feeding/Parenteral Nutrition Order Set (Adult)
Review Due Date: 2016 May PATIENT CARE ORDERS Weight (kg) Known Adverse Reactions or Intolerances DRUG No Yes (list) FOOD No Yes (list) LATEX No Yes ***See Suggestions for Management (on reverse)*** ***If
More informationManaging the Hospitalized Patient on Insulin: Care Transition. Catie Prinzing MSN, APRN, CNS
Managing the Hospitalized Patient on Insulin: Care Transition Catie Prinzing MSN, APRN, CNS Diabetes and Hospitalization People with DM are hospitalized 3x more frequently than patients without diabetes
More informationINSULIN PUMP THERAPY
INSULIN PUMP THERAPY Information Leaflet Your Health. Our Priority. Page 2 of 5 Insulin management plan for pregnant women using insulin pump therapy If at any point, you are not able to control your blood
More informationONCE ONLY GLUCAGON and Fast Acting Glucose gel (PGD) For nurse administration under Patient Group Direction (Trust wide PGD in place)
ADULT INSULIN PRERIPTION AND BLOOD GLUCOSE MONITORING CHART Ward CONSULTANT DATE OF ADMISSION Please affix Patient s label here Ward Ward.../...year PATIENT NAME....... DATE OF BIRTH... NHS NUMBER.......
More informationGlycaemic Control in Adults with Type 1 Diabetes
Glycaemic Control in Adults with Type 1 Diabetes Aim(s) and objective(s) This document aims to provide guidance on good clinical practice in managing glycaemic control in adult patients with Type 1 Diabetes
More informationCase Study. Objectives
Case Study One in a series of case studies developed to stimulate enhancement of problem-solving techniques for physicians and nurses and paramedical personnel when challenged by patients who present with
More informationR e s i d e n t G r a n d R o u n d s. Diagnosis and Management of Diabetic Ketoacidosis in Adults
R e s i d e n t G r a n d R o u n d s Series Editor: Mark A. Perazella, MD Diagnosis and Management of Diabetic Ketoacidosis in Adults Baligh Ramzi Yehia, MD Kelly C. Epps, MD Sherita Hill Golden, MD,
More informationAbdulaziz Al-Subaie. Anfal Al-Shalwi
Abdulaziz Al-Subaie Anfal Al-Shalwi Introduction what is diabetes mellitus? A chronic metabolic disorder characterized by high blood glucose level caused by insulin deficiency and sometimes accompanied
More informationInsulin Analogues versus Pump Therapy in Type 2 Diabetes: Benefits from Pump Therapy
Insulin Analogues versus Pump Therapy in Type 2 Diabetes: Benefits from Pump Therapy Eric RENARD, MD, PhD Endocrinology Dept, Lapeyronie Hospital Montpellier, France e-renard@chu-montpellier.fr Type 2
More informationInsulin Pump Therapy
CHILDREN S SERVICES Insulin Pump Therapy These guidelines are not intended for starting a patient on an insulin pump. They are intended to give staff not part of the diabetic team information regarding
More informationCalculating Insulin Dose
Calculating Insulin Dose First, some basic things to know about insulin: Approximately 40-50% of the total daily insulin dose is to replace insulin overnight, when you are fasting and between meals. This
More informationCauses, incidence, and risk factors
Causes, incidence, and risk factors Insulin is a hormone produced by the pancreas to control blood sugar. Diabetes can be caused by too little insulin, resistance to insulin, or both. To understand diabetes,
More informationSolomon S. Steiner, Lutz Heinemann, Roderike Pohl, Frank Flacke, Andreas Pfützner, Patrick V. Simms, Marcus Hompesch. EASD September 18, 2007
Pharmacokinetics and Pharmacodynamics of Insulin VIAject TM, Insulin Lispro and Regular Human Insulin When Injected Subcutaneously Immediately Before a Meal in Patients with Type 1 Diabetes. Solomon S.
More informationPEDIATRIC DIABETIC KETOACIDOSIS
PEDIATRIC DIABETIC KETOACIDOSIS October 2011 Quality Improvement Resources Illinois Emergency Medical Services for Children is a collaborative program between the Illinois Department of Public Health and
More informationThe Basics of Insulin Pump Therapy
The Basics of Insulin Pump Therapy Table of Contents The Basics of Insulin Pump Therapy Introduction Welcome... 3 Chapter 1 Balancing Glucose and Insulin............................. 10 Section 1: Glucose,
More informationThe basal plus strategy. Denis Raccah, MD, PhD Professor of Medicine University Hospital Sainte Marguerite Marseille FRANCE
The basal plus strategy Denis Raccah, MD, PhD Professor of Medicine University Hospital Sainte Marguerite Marseille FRANCE ADA/EASD guidelines recommend use of basal insulin as early as the second step
More informationNICE Pathways bring together all NICE guidance, quality standards and other NICE information on a specific topic.
Diabetic ketoacidosis in children and young people bring together all NICE guidance, quality standards and other NICE information on a specific topic. are interactive and designed to be used online. They
More informationManagement of Children with newly diagnosed type 1 diabetes (up until their 18th Birthday)
Title: Author: Speciality / Division: Directorate: CLINICAL GUIDELINES ID TAG Management of Children with newly diagnosed type 1 diabetes (up until their 18th Birthday) Dr Teresa Mulroe and Dr Sarinda
More informationSLIDING SCALE INSULIN ASPART PROTOCOL PLAN
Weight Allergies Patient Care Accucheck Per Sliding Scale Insulin Frequency AC & HS AC & HS 3 days TID BID q12h q6h q6h 24 hr q4h q2h Sliding Scale Insulin Protocol Follow SSI Reference Text Medications
More informationImplementing Treatment Guidelines for Diabetic Ketoacidosis in the Emergency. Department. Heidi Hanks, RN, BSN, DNP Candidate
Implementing Treatment Guidelines for Diabetic Ketoacidosis in the Emergency Department Heidi Hanks, RN, BSN, DNP Candidate George S. and Dolores Doré Eccles Graduate Fellow University of Utah In partial
More informationPediatric Diabetic Ketoacidosis. Nicholas Slamon M.D. dupont Hospital for Children
Pediatric Diabetic Ketoacidosis Nicholas Slamon M.D. dupont Hospital for Children Causes Failure to take insulin Acute stress, trauma, or illness (often febrile) which elevates the counterregulatory hormones
More informationBasal Rate Testing Blood sugar is affected at any time by 1) basal insulin 2) food (carbohydrate) intake 3) bolus insulin (meal time and correction)
Basal Rate Testing Blood sugar is affected at any time by 1) basal insulin 2) food (carbohydrate) intake 3) bolus insulin (meal time and correction) 4) activity and 5) other factors such as stress and
More informationNICE insulin algorithm function. Select 'Calculate insulin dose' from web menu
NICE SUGAR STUDY TREATMENT ALGORITHM The NICE-SUGAR STUDY blood glucose management algorithm ( Algorithm ) has been designed for use solely by medical practitioners treating patients enrolled in the NICE-SUGAR
More informationExternal Insulin Pumps Corporate Medical Policy
External Insulin Pumps Corporate Medical Policy File name: External Insulin Pumps File code: UM.DME.02 Origination: 4/2006 Last Review: 02/2014 (ICD-10 remediation only) Next Review: 10/2014 Effective
More informationHUMULIN R REGULAR INSULIN HUMAN INJECTION, USP (rdna ORIGIN) 100 UNITS PER ML (U-100)
1 PATIENT INFORMATION HUMULIN R REGULAR INSULIN HUMAN INJECTION, USP (rdna ORIGIN) 100 UNITS PER ML (U-100) WARNINGS Do not share your syringes with other people, even if the needle has been changed. You
More informationKetones & diabetes; Reduce your risk!
Ketones & diabetes; Reduce your risk! Booklet includes Sick Day Wallet Card Ketones 101 Do I really need to know this? by Helen Jones RN, MSN, CSE YES! The word Ketone is important for you to know if you
More informationBOLUS INSULIN DOSAGES H. Peter Chase, MD and Erin Cobry, BS
CHAPTER 6: BOLUS INSULIN DOSAGES H. Peter Chase, MD and Erin Cobry, BS WHAT IS BOLUS INSULIN? Bolus insulin dosages refer to the quick bursts of insulin given to cover the carbohydrates in meals or snacks
More informationEfficacy and Safety of Insulin Aspart in Patients with Type 1 Diabetes Mellitus
Clin Pediatr Endocrinol 2002; 11(2), 87-92 Copyright 2002 by The Japanese Society for Pediatric Endocrinology Original Efficacy and Safety of Insulin Aspart in Patients with Type 1 Diabetes Mellitus Toshikazu
More informationBasal and Bolus Insulin 7/16/2014. Jackie Aday RN, BSN, CDE Jeni Neighbors RN, BSN, CDE. BASAL: Small amount of insulin infused every few minutes
Jackie Aday RN, BSN, CDE Jeni Neighbors RN, BSN, CDE Insulin Pump Therapy Open looped system in which a small amount of insulin is continuously infused through a cannula or needle (basal rate) Larger doses
More informationBASAL BOLUS INSULIN FOR MEDICAL- SURGICAL INPATIENTS
BASAL BOLUS INSULIN FOR MEDICAL- SURGICAL INPATIENTS C O N T A C T D I A B E T E S S E R V I C E S F O R M O R E I N F O R M A T I O N 8 4 7-9 1 7-6 9 0 7 THIS SLIDE PRESENTATION WAS PREPARED BY SUE DROGOS,
More informationInsulin: A Practice Update. Department of Nursing Staff Development Elizabeth Borgelt, MS, RN
Insulin: A Practice Update Department of Nursing Staff Development Elizabeth Borgelt, MS, RN Learning Outcome The learner will be able to identify the different types of insulins available, their actions,
More informationSponsor / Company: Sanofi Drug substance(s): HOE901 (insulin glargine)
These results are supplied for informational purposes only. Prescribing decisions should be made based on the approved package insert in the country of prescription. Sponsor / Company: Sanofi Drug substance(s):
More informationRecommendations: Other Supportive Therapy of Severe Sepsis*
Recommendations: Other Supportive Therapy of Severe Sepsis* K. Blood Product Administration 1. Once tissue hypoperfusion has resolved and in the absence of extenuating circumstances, such as myocardial
More informationTYPE 2 DIABETES MELLITIS (INSULIN AND/OR METFORMIN) CARE OF WOMEN IN BIRTHING SUITE
TYPE 2 DIABETES MELLITIS (INSULIN AND/OR METFORMIN) CARE OF WOMEN IN BIRTHING SUITE DEFINITION Type 2 Diabetes is characterised by insulin resistance and relative impairment of insulin secretion leading
More informationSection 6: Diabetes Emergencies
Section 6: Diabetes Emergencies SECTION OVERVIEW General Overview Low Blood Glucose (Hypoglycemia) Glucagon High Blood Glucose (Hyperglycemia) Diabetic Ketoacidosis Monitoring Ketones Emergency Medical
More informationSouthwest Paediatric Diabetes Regional Network Integrated Care Pathway for Children and Young People with Diabetic Ketoacidosis
Date Additional Information Signature Name: Date of Birth: DD /MM /YYYY Hospital Number: NHS Number: (or affix hospital label here) Southwest Paediatric Diabetes Regional Network Integrated Care Pathway
More informationContinuous Subcutaneous Insulin Infusion (CSII) pump therapy
Continuous Subcutaneous Insulin Infusion (CSII) pump therapy GHPI1267_04_15 Department: Diabetes team Review due: April 2018 www.gloshospitals.nhs.uk 21 BETTER FOR YOU BETTER FOR YOU 1 Introduction This
More informationInsulin: Breaking Barriers Enhancing Therapies. Jerry Meece, RPh, FACA, CDE jmeece12@cooke.net
Insulin: Breaking Barriers Enhancing Therapies Jerry Meece, RPh, FACA, CDE jmeece12@cooke.net Questions To Address Who are candidates for insulin? When do we start insulin? How do the different types of
More informationCLINICAL GUIDELINE FOR THE MANAGEMENT OF HIGH BLOOD GLUCOSE LEVELS AND SICK DAYS ON AN INSULIN PUMP. 1. Aim/Purpose of this Guideline
CLINICAL GUIDELINE FOR THE MANAGEMENT OF HIGH BLOOD GLUCOSE LEVELS AND SICK DAYS ON AN INSULIN PUMP. 1. Aim/Purpose of this Guideline 1.1. The purpose of this guideline is to give clear information and
More informationHow To Manage Diabetes
INSULIN PUMPS PHYSIOLOGIC INSULIN SECRETION Daniel L. Metzger, MD, FAAP, FRCPC INSULIN PUMP INFUSION SETS BOLUS BASAL Breakfast Bed Dinner Snack Lunch Breakfast BRANDS OF PUMPS ADVANTAGES I ANIMAS MINIMED
More informationThis guideline is for the management of Adult patients with Diabetes Mellitus using insulin pump therapy during admission to hospital
CLINICAL GUIDELINE FOR THE MANAGEMENT OF ADULT PATIENTS DIABETES MELLITUS USING INSULIN PUMP THERAPY (Continuous Subcutaneous Insulin Infusion (CSII)), DURING ADMISSION TO HOSPITAL 1. Aim/Purpose of this
More informationThere seem to be inconsistencies regarding diabetic management in
Society of Ambulatory Anesthesia (SAMBA) Consensus Statement on Perioperative Blood Glucose Management in Diabetic Patients Undergoing Ambulatory Surgery Review of the consensus statement and additional
More informationat The Valley Hospital (TVH) for Nursing Students/Nursing Instructors 2012
at The Valley Hospital (TVH) for Nursing Students/Nursing Instructors 2012 Subject - Insulin Safety Background Insulin known to be high risk medication Can promote serious hypoglycemia if given incorrectly
More informationInsulin Initiation and Intensification
Insulin Initiation and Intensification ANDREW S. RHINEHART, MD, FACP, CDE MEDICAL DIRECTOR AND DIABETOLOGIST JOHNSTON MEMORIAL DIABETES CARE CENTER Objectives Understand the pharmacodynamics and pharmacokinetics
More informationDIABETIC KETOACIDOSIS
DIABETIC KETOACIDOSIS Janet Lin, MD, MPH 1. Diabetes Mellitus (DM) a. Historical Perspective i. First described in Egypt 3000 years ago ii. Named diabetes (for siphon) mellitus (for honey) by Celsus at
More informationDepartment Of Biochemistry. Subject: Diabetes Mellitus. Supervisor: Dr.Hazim Allawi & Dr.Omar Akram Prepared by : Shahad Ismael. 2 nd stage.
Department Of Biochemistry Subject: Diabetes Mellitus Supervisor: Dr.Hazim Allawi & Dr.Omar Akram Prepared by : Shahad Ismael. 2 nd stage. Diabetes mellitus : Type 1 & Type 2 What is diabestes mellitus?
More information